Tables

Table 2.1	List of some key inspection/licensing/accreditation/certification standards
Table 8.1	Whole Blood, Leucocyte Depleted – additional tests
Table 8.2	Red Cells, Leucocyte Depleted – additional tests
Table 8.3	Red Cells in Additive Solution, Leucocyte Depleted – additional tests
Table 8.4	Red Cells, Washed, Leucocyte Depleted – additional tests
Table 8.5	Red Cells, Thawed and Washed, Leucocyte Depleted – additional tests
Table 8.6	Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted – additional tests
Table 8.7	Platelets, Apheresis, Leucocyte Depleted – additional tests
Table 8.8	Platelets, Suspended in Platelet Additive Solution, Leucocyte Depleted – additional tests
Table 8.9	Granulocytes, Apheresis – additional tests
Table 8.10	Fresh Frozen Plasma, Leucocyte Depleted – additional tests
Table 8.11	Fresh Frozen Plasma, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.12	Cryoprecipitate, Leucocyte Depleted – additional tests
Table 8.13	Plasma, Cryoprecipitate Depleted, Leucocyte Depleted – additional tests
Table 8.14	Red Cells for Intrauterine Transfusion (IUT), Leucocyte Depleted – additional tests
Table 8.15	Whole Blood for Exchange Transfusion, Leucocyte Depleted – additional tests
Table 8.16	Red Cells for Exchange Transfusion, Leucocyte Depleted – additional tests
Table 8.17	Red Cells for Neonates and Infants, Leucocyte Depleted – additional tests
Table 8.18	Red Cells in Additive Solution for Neonates and Infants, Leucocyte Depleted – additional tests
Table 8.19	Fresh Frozen Plasma, Neonatal Use, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.20	Cryoprecipitate, Methylene Blue Treated and Removed, Leucocyte Depleted – additional tests
Table 8.21	Platelets for IUT, Leucocyte Depleted – additional tests
Table 8.22	Platelets for Neonatal Use, Leucocyte Depleted – additional tests
Table 8.23	Red cell components
Table 8.24	Platelet and granulocyte components
Table 8.25	Plasma components
Table 8.26	Neonatal and infant red cell components
Table 8.27	Neonatal and infant platelet components
Table 8.28	Neonatal and infant plasma components
Table 8.29	Blood components suitable for use in intrauterine and exchange transfusion and neonates and infants under one year, specific requirements
Table 9.1	Testing of novel components
Table 9.2	Evaluation of new red cell components for transfusion: recommended tests
Table 9.3	In vitro assessment
Table 9.4	Evaluation of new platelet components for transfusion
Table 9.5	Evaluation of novel plasma components
Table 9.6	Generic flowchart of apheresis equipment acceptance
Table 9.7	Summary of testing numbers required for evaluations and validations
Table 12.1	Label colour coding
Table 12.2	Grading system for serological tests
Table 12.3	Requirements for conventional blood typing reagents
Table 12.4	Chequerboard test format
Table 12.5	Complement C3 and C4 activation
Table 13.1	Minimum release criteria for blood products with antibodies of probable clinical significance
Table 13.2	Test monitor red cell samples
Table 14.1	Timing of pre-transfusion samples
Table 14.2	Suggested maximum storage time of samples
Table 14.3	Controls for manual and automated ABO and D grouping
Table 15.1	Dilution of UK reference reagent
Table 15.2	HLA antigens that are defined by serological typing
Table 15.3	Characterization of HLA-specific antibodies
Table 16.1	Current nomenclature for human neutrophil antigens and corresponding antibodies
Table 17.1	Current HPA nomenclature for platelet-specific alloantigen and alloantibody specificities
Table 22.1	Microbiological testing for tissue donors
Table 23.1	Temperature/time relationships for banked tissues
Table 23.2	Air classification system for manufacture of sterile medicinal products
Table 23.3	Comparison of British, European and American classifications
Table 23.4	Microbiological monitoring of controlled work areas
Table 23.5	Ethylene oxide and ethylene chlorohydrin residue levels
Table 23.6	Minimum donor/recipient data set to be kept
Table 24.1	Requirements for the timing of testing
Table 24.2	Label content adapted from FACT-JACIE
Table 24.3	Label content for HPC-C adapted from NETCORD-FACT
Table 25.1	Centre codes and names
Table 25.2a	Blood group classifications
Table 25.2b	Blood group and donation use limitations
Table 25.2c	Blood group and donation use label text
Table 25.3	Historic blood group classifications (only for use on 'Use in emergency only' labels)
Table 25.4	Manufacturers'codes
Table 26.1	Statements of product status
Table 26.2	Glossary: uniform labelling of human tissue products
Table 27.1	Envelope definition
Table 27.2	Message protocol numbers
Table 27.3	Message protocol 000001: blood component dispatch information: administrationline
Table 27.4	Message protocol 000001: blood component dispatch information: dispatch line
Table 27.5	Message protocol 000001: blood component dispatch information. Field 10: Red cell phenotype field – antigen codes
Table 27.6	Message protocol 000001: blood component dispatch information. Field 14: Platelet-specific phenotype
Table 27.7	Message protocol 000002: blood derivative dispatch information: administrationline
Table 27.8	Message protocol 000002: blood derivative dispatch information: dispatch line
Table 27.9	Message protocol 000003: reagent dispatch information: administrationline
Table 27.10	Message protocol 000003: reagent dispatch information: dispatch line
Table 27.11	Message protocol 000004: blood component dispatch acknowledgement: administrationline
Table 27.12	Message protocol 000004: blood component dispatch acknowledgement: dispatch line
Table 27.13	Message protocol 000005: blood component fate information: data line
Table 27.14	Message protocol 000005: blood component fate information. Field 8: wasted classification code
Table A1.1	Serological, virological and other preparations
Table A1.2	Coagulation preparations: WHO International Standards
Table A1.3	Coagulation preparations: British Standards
Table A2.1	Mapping from characters to ISO 7064 check values
Table A2.2	Example of displayed numbers